id:"swepub:oai:lup.lub.lu.se:dae7a98f-14c7-4f9e-b647-c77f723fe40c"
Search: id:"swepub:oai:lup.lub.lu.se:dae7a98f-14c7-4f9e-b647-c77f723fe40c" > Case-control estima...
- 1 of 1
- Previous record
- Next record
- To hitlist
- Kanerva, Anna (author)
Case-control estimation of the impact of oncolytic adenovirus on the survival of patients with refractory solid tumors.
- Article/chapterEnglish2015
Publisher, publication year, extent ...
- Elsevier BV,2015
Numbers
- LIBRIS-ID:oai:lup.lub.lu.se:dae7a98f-14c7-4f9e-b647-c77f723fe40c
- https://lup.lub.lu.se/record/4817098URI
- https://doi.org/10.1038/mt.2014.218DOI
- http://kipublications.ki.se/Default.aspx?queryparsed=id:130632691URI
Supplementary language notes
- Language:English
- Summary in:English
Part of subdatabase
- SwePubSwePub
Classification
Notes
- Oncolytic immunotherapy with cytokine armed replication competent viruses is an emerging approach in cancer treatment. In a recent randomized trial an increase in response rate was seen but the effect on overall survival is not known with any virus. To facilitate randomized trials, we performed a case-control study assessing the survival of 270 patients treated in an Advanced Therapy Access Program (ATAP), in comparison to matched concurrent controls from the same hospital. The overall survival of all virus treated patients was not increased over controls. However, when analysis was restricted to GMCSF-sensitive tumor types treated with GMSCF-coding viruses, a significant improvement in median survival was present (From 170 to 208 days, P = 0.0012, N=148). An even larger difference was seen when analysis was restricted to good performance score patients (193 versus 292 days, P = 0.034, N=90). The survival of ovarian cancer patients was especially promising as median survival nearly quadrupled (P = 0.0003, N=37). These preliminary data lend support to initiation of randomized clinical trials with GMCSF-coding oncolytic adenoviruses.Molecular Therapy (2014); doi:10.1038/mt.2014.218.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
- Koski, Anniina (author)
- Liikanen, Ilkka (author)
- Oksanen, Minna (author)
- Joensuu, Timo (author)
- Hemminki, Otto (author)
- Palmgren, JuniKarolinska Institutet (author)
- Hemminki, KariLund University,Lunds universitet,Allmänmedicin och klinisk epidemiologi,Forskargrupper vid Lunds universitet,Family Medicine and Clinical Epidemiology,Lund University Research Groups(Swepub:lu)med-khk (author)
- Hemminki, Akseli (author)
- Karolinska InstitutetAllmänmedicin och klinisk epidemiologi (creator_code:org_t)
Related titles
- In:Molecular Therapy: Elsevier BV23:2, s. 321-3291525-00241525-0016
Internet link
- http://www.ncbi.nlm.nih.gov/pubmed/25381801?dopt=AbstractFULLTEXT
- http://dx.doi.org/10.1038/mt.2014.218FULLTEXT
- http://www.cell.com/article/S1525001616300429/pdf
- https://lup.lub.lu.se/record/4817098
- https://doi.org/10.1038/mt.2014.218
- http://kipublications.ki.se/Default.aspx?queryparsed=id:130632691
Find in a library
- Molecular Therapy (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Kanerva, Anna
- Koski, Anniina
- Liikanen, Ilkka
- Oksanen, Minna
- Joensuu, Timo
- Hemminki, Otto
- show more...
- Palmgren, Juni
- Hemminki, Kari
- Hemminki, Akseli
- show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Basic Medicine
- and Medical Genetics
- Articles in the publication
- Molecular Therap ...
- By the university
- Lund University
- Karolinska Institutet
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
